Dr. Tosoian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- University of Michigan Medical CenterTranslational Cancer Research, Urologic Oncology, 2018 - 2021
- Johns Hopkins UniversityResidency, Urology, 2012 - 2018
- Johns Hopkins University School of MedicineClass of 2012, MD, MPH
Certifications & Licensure
- TN State Medical License 2021 - 2025
- MI State Medical License 2018 - 2022
- American Board of Urology Urology
- American Board of UrologyUrology
Publications & Presentations
PubMed
- 102 citationsA Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.Neil K. Jairath, Alan Dal Pra, Randy Vince, Robert T. Dess, William C. Jackson
European Urology. 2021-03-01 - 13 citationsOptimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.Mohammad R Siddiqui, Eric V Li, Sai K S R Kumar, Anna Busza, Jasmine S Lin
Prostate Cancer and Prostatic Diseases. 2023-09-01 - 57 citationsUse of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJeffrey J. Tosoian, Sasha C. Druskin, Darian Andreas, Patrick Mullane, Meera Chappidi
Prostate Cancer and Prostatic Diseases. 2017-01-24
Journal Articles
- Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy from a Statewide Improvement Collabora...Gregory B Auffenberg, Jeffrey Tosoian, Richard Sarle, William K Johnston, Eduardo Kleer, Khurshid R Ghani, James Montie, JAMA Surgery
- Association of Tumor-Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate CancerTamara L Lotan, Edward M Schaeffer, Jeffrey J Tosoian, Scott A Tomlins, Nature
Authored Content
- The Androgen Signaling Axis and Risk Stratification for High-Grade Prostate CancerMarch 2018
- Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving PracticeFebruary 2018
Press Mentions
- Men with Prostate Cancer Live Longer if Relatives Had ItFebruary 10th, 2023
- Drop in PSA Tied to Better Outcomes of Apalutamide Therapy in Prostate CancerJanuary 3rd, 2022
- Surveillance for Prostate Cancer Is on the Rise -- Do Men Stick It Out?August 23rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: